个人学术档案

J Stuart Elborn

Imperial College and Royal Brompton Hospital, London

在 imperial.ac.uk 的电子邮件经过验证

被引用次数：47025

Cystic fibrosis lung disease

William Guggino

Professor and Director of Physiology, Johns Hopkins University

在 jhmi.edu 的电子邮件经过验证

被引用次数：42613

salt and water channels Cystic fibrosis Polycystic Kidney disease

Paul B. McCray, Jr., MD

Professor, Department of Pediatrics, Pappajohn Biomedical Institute, University of Iowa

在 uiowa.edu 的电子邮件经过验证

被引用次数：40984

cystic fibrosis host-pathogen interactions innate immunity gene therapy

John F. Engelhardt, Ph.D.

Professor and Chair, Department of Anatomy and Cell Biology

在 uiowa.edu 的电子邮件经过验证

被引用次数：38998

gene therapy cystic fibrosis lung stem cells animal models redox signaling

Batsheva Kerem

Professor in Genetics

在 mail.huji.ac.il 的电子邮件经过验证

被引用次数：36817

Cystic Fibrosis Oligonucleotide therapy Genomic instability Replication stress Fragile sites

Felix Ratjen

University of Toronto

在 sickkids.ca 的电子邮件经过验证

被引用次数：36369

Cystic Fibrosis early disease outcome measures HHT

Antonio Oliver

Microbiology, Hospital Son Espases, Instituto de Investigación Sanitaria Illes Balears …

在 ssib.es 的电子邮件经过验证

被引用次数：34701

Microbiology Antimicrobial resistance Pseudomonas aeruginosa bacterial evolution cystic fibrosis

Vin Tangpricha

Professor of Medicine, Emory University

在 emory.edu 的电子邮件经过验证

被引用次数：32652

Vitamin D Osteoporosis Cystic Fibrosis Transgender Transgender Medicine

Claude Ferec

MD-PhD, Pharm, Professor of Genetics, INSERM and University of Brest

在 univ-brest.fr 的电子邮件经过验证

被引用次数：31462

Human Genetics Cystic Fibrosis ADPKD Chronic Pancreatitis

Michael Konstan

Case Western Reserve University School of Medicine

在 case.edu 的电子邮件经过验证

被引用次数：30246

Cystic Fibrosis Clinical Trial Design

1 - 10